| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $7,662,721 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01ES032396 | A university-community partnership to reduce exposure to disinfection byproducts in Appalachia | 000 | 6 | NIH | 12/11/2025 | $368,566 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01ES033767 | Phthalate-Induced Dysregulation of Prostaglandin and Angiogenic Function During Ovulation in Women | 000 | 5 | NIH | 12/12/2025 | $440,911 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG084670 | Emerging role of PAD4 mediated TDP-43 citrullination in the neuropathology of LATE and Alzheimer’s Disease Related Dementias | 000 | 3 | NIH | 1/19/2026 | $585,180 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R03EB037115 | In situ forming implant drug delivery for non-addictive post-operative analgesia | 000 | 2 | NIH | 12/9/2025 | $74,947 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AG098189 | Decoding the Muscle Epitranscriptome: Deep Learning Detection of RNA Modifications in Aging Muscle | 000 | 1 | NIH | 1/21/2026 | $616,000 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | G08LM014412 | DASH-ing to Heart Health: Supporting Low-Income African American Women with an Interactive "Meals that Heal" Resource Book | 000 | 3 | NIH | 12/18/2025 | $254,234 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG082142 | MicroRNA lipid-nanoparticle based therapy targets neuroinflammation and ApoE dysregulation in Alzheimer’s disease | 000 | 4 | NIH | 12/22/2025 | $586,701 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R35GM156952 | Gene regulatory network plasticity in social behavior | 000 | 2 | NIH | 1/16/2026 | $328,500 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21HD117520 | Evaluating causes for failure to thrive in a Noonan-like syndrome with loose anagen hair (NSLH) patients using NSLH vertebrate model | 000 | 2 | NIH | 12/2/2025 | $173,250 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AG098743 | Arginine Sensor (CASTOR1) Dysfunction Drives Tauopathy | 000 | 1 | NIH | 1/21/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK124626 | Mechanisms for activation of beige adipose tissue in humans | 000 | 5 | NIH | 1/13/2026 | $448,041 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R00AR081367 | Contribution of ribosome specialization to the pathophysiology of muscular dystrophy | 000 | 5 | NIH | 12/2/2025 | $218,967 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K01DK128022 | Elucidating Molecular Mechanisms Linking Fructose to Cholesterol Metabolism | 000 | 5 | NIH | 12/18/2025 | $148,186 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | UH3DE032621 | Empowering dentists to reduce opioid prescriptions to young people | 000 | 4 | NIH | 12/11/2025 | $987,227 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31AG087618 | Using the gut microbiome to treat disuse atrophy in aging. | 000 | 2 | NIH | 1/14/2026 | $44,495 |
| | 2026 | 2026 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | T9952106 | Value-Based Medical Student Education Training Program | 01 | 3 | HRSA | 12/9/2025 | $1,175,000 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AR084282 | Using the gut microbiome to treat skeletal muscle atrophy | 000 | 2 | NIH | 1/16/2026 | $399,502 |
| | 2026 | 2026 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG080589 | APOE Allele Switching as a Therapeutic Approach for Alzheimer's Disease | 000 | 4 | NIH | 12/10/2025 | $578,038 |
| | 2026 | 2025 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU58DP007144 | Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations | 02 | 4 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU58DP007144 | Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations | 02 | 4 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU58DP007144 | Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations | 02 | 4 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | T2653690 | Opioid-Impacted Family Support Program | 02 | 2 | HRSA | 1/9/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | T2653690 | Opioid-Impacted Family Support Program | 02 | 2 | HRSA | 1/9/2026 | $0 |
| | 2026 | 2025 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU58DP007144 | Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations | 02 | 4 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU58DP007144 | Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations | 02 | 4 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU58DP007144 | Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations | 02 | 4 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU58DP007144 | Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations | 02 | 4 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU58DP007144 | Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations | 02 | 4 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU58DP007144 | Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations | 02 | 4 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU58DP007144 | Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations | 02 | 4 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU58DP007144 | Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations | 02 | 4 | CDC | 11/10/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K99AG084892 | Gabapentin prescription and health-related outcomes in older adults | 000 | 2 | NIH | 1/16/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG068055 | Identifying Associations between Brain Iron, Neurocognitive Networks and Protective Factors | 000 | 5 | NIH | 12/3/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG070830 | Contributions of astrocyte RelA signaling in aging-related neurodegenerative sequelae following TBI | 000 | 5 | NIH | 12/8/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AA028246 | Cross-Tailoring Integrative Alcohol and Risky Sex Feedback for College Students: A Hybrid Type 1 Effectiveness-Implementation Trial | 000 | 5 | NIH | 12/11/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA053070 | Functional and Genomic Signatures of Escalated Fentanyl Use | 000 | 5 | NIH | 12/5/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U2FFD008699 | University of Kentucky Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives | 000 | 1 | FDA | 11/24/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA249734 | Targeting Lipid Metabolism in Colorectal Cancer | 000 | 5 | NIH | 1/7/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA064144 | Advancing Non-Abstinence Outcomes in the Treatment of Methamphetamine Use Disorder | 000 | 1 | NIH | 12/11/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21ES036036 | R21-UKY East Palestine Train Derailment Health Tracking Study | 000 | 2 | NIH | 11/25/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01MH125903 | Astrocyte-derived signals for neuronal and behavioral modulation and its implications in mental illness. | 000 | 5 | NIH | 1/22/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K08DK124566 | Muscle bone interaction and its role in diabetic bone disease of Type I diabetes | 000 | 5 | NIH | 10/13/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R24OD010435 | Research Resources for Model Amphibians | 000 | 23 | NIH | 12/18/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U7A50519 | State Maternal Health Innovation Program | 01 | 3 | HRSA | 12/11/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG066724 | Novel gastrocnemius muscle characteristics in peripheral artery disease patients associated with impaired functional performance | 000 | 5 | NIH | 11/11/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA259580 | Defining the Critical Function and Regulation of NNMT in Breast Cancer Progression and Metastasis | 000 | 5 | NIH | 1/22/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS119165 | Translational Approaches to Mitigate Enhanced Alzheimer’s Disease Risk Following a Mild TBI | 000 | 3 | NIH | 1/21/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R00HD108801 | Sex and physiological State dependent molecular characterization of circuits governing parental behavior | 000 | 3 | NIH | 1/7/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21NS135089 | Cannabidiol (CBD) as a Potential Therapeutic for Experimental Subarachnoid Hemorrhage | 000 | 2 | NIH | 10/7/2025 | $0 |
|
